CAS MEDICAL SYSTEMS INC 
By CASMED Announces Third Quarter 2013 Financial Results
Launch of Next-Generation Cerebral Oximetry Products Underway
Conference Call Begins at 10:00 a.m. ET Today
Branford, Conn. (November 12, 2013) - CAS Medical Systems, Inc. (NASDAQ: CASM), (CASMED), a leader in medical devices for non-invasive patient monitoring, today reported financial results for the three and nine months ended September 30, 2013.
Net sales for the third quarter of 2013 were $5.4 million, compared with $6.1 million for the third quarter of 2012. The decline was primarily due to lower sales of vital signs monitors to the Veterans Administration. The net loss applicable to common stockholders for the third quarter of 2013, including an impairment charge, was $3.3 million, or ($0.19) per common share, compared with a net loss applicable to common stockholders of $1.8 million, or ($0.14) per common share, for the third quarter of 2012.
Highlights of the third quarter of 2013 and recent weeks include:
Launching the next-generation FORE-SIGHT ELITE" cerebral oximeter monitor and sensors;
Increasing the installed base of all FORE-SIGHT
